BIOMARIN PHARMACEUTICAL INC: operating_income
| Value | {"amount": 149562000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | superseded |
| Entity | BIOMARIN PHARMACEUTICAL INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:17:13.171852+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/256a15f7-16a3-4b20-9e9b-020a3ca8189e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001048477-23-000009Retrieved: 2026-08-19T10:17:13.171852+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001048477/operating-income/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/256a15f7-16a3-4b20-9e9b-020a3ca8189e
History
- no predecessors — first report